[抗胰岛素:一个正在进行的叙事]
Sophie Vandenberghe-Dürr1, Thomas Harr1, Frederik Vandenberghe2
1Service d'immunologie et d'allergologie, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.
Revue medicale suisse
|April 3, 2024
概括
本综述涵盖了组胺受体生理学,详细介绍了H1,H2,H3和H4对手. 它探讨了新的药物开发,治疗用途和抗组胺剂的副作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生理学 生理学 生理学
- 药物开发 药物开发
背景情况:
- 胺通过特定的受体调解各种生理过程.
- 早期的H1和H2抗剂彻底改变了过敏和酸性反流治疗方法.
- 最近发现的H3和H4受体开辟了新的治疗途径.
结论:
- 基因组胺受体对手的开发显著提升了医疗治疗方法.
- 对H3和H4受体的持续研究有望提出新的治疗策略.
- 本综述提供了对组胺药理学和抗组胺治疗方法的重要见解.
相关概念视频
Upper Respiratory Drugs: First and Second-Generation Antihistamines
267
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
267
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
Cholinergic Antagonists: Therapeutic Uses
745
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
745
Cholinergic Antagonists: Pharmacokinetics
437
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
437
Allergic Reactions
27.3K
Overview
27.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
443
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
443


